| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 0 | ||||
| Sells | 6 | -335K | 100% | $32.49 | -$10.9M |
| Net | -6 | -335K | -100% | -$10.9M |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Joseph Ciaffoni | President and CEO, Director | $15M | -$2.21M | -12.8% | Feb 12, 2024 |
| Alison B. Fleming | EVP & Chief Technical Officer | $4.64M | Aug 10, 2021 | ||
| Colleen Tupper | EVP & Chief Financial Officer | $4.48M | -$674K | -13.1% | May 28, 2024 |
| Shirley R. Kuhlmann | EVP and General Counsel | $4.46M | -$2.25M | -33.5% | Sep 5, 2024 |
| Richard Malamut | EVP and Chief Medical Officer | $4.2M | Feb 10, 2022 | ||
| Scott Dreyer | EVP & Chief Commercial Officer | $3.6M | -$4.79M | -57.1% | May 23, 2024 |
| John G. Freund | Director | $3.1M | May 16, 2024 | ||
| Gino Santini | Director | $2.44M | May 16, 2024 | ||
| Thomas B. Smith | EVP and Chief Medical Officer | $2.33M | -$36.6K | -1.54% | Feb 29, 2024 |
| John A. Fallon | Director | $1.77M | May 16, 2024 | ||
| Gwen A. Melincoff | Director | $1.69M | May 16, 2024 | ||
| Garen Bohlin | Director | $1.69M | -$936K | -35.6% | May 14, 2024 |
| Neil F. McFarlane | Director | $1.59M | May 16, 2024 | ||
| Rita J. Balice-Gordon | Director | $1.5M | May 16, 2024 | ||
| Michael Thomas Heffernan | Director | $1.47M | May 16, 2024 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|